The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial
EuroIntervention 2014;10:672-680 published online ahead of print January 2014. DOI: 10.4244/EIJV10I6A118
Yao-Jun Zhang1,2, MD, PhD; Christos V. Bourantas1, MD, PhD; Takashi Muramatsu1, MD, PhD; Javaid Iqbal1, MRCP, PhD; Vasim Farooq1, MBChB, MRCP; Roberto Diletti1, MD; Carlos A.M. Campos1,3, MD; Yoshinobu Onuma1, MD; Hector M. Garcia-Garcia1, MD, PhD; Patrick W. Serruys1*, MD, PhD
1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China; 3. Heart Institute (InCor), University of São Paulo Medical School, Sao Paulo, Brazil
Aims: The study sought to compare the acute gain and two-year follow-up late lumen loss (LLL) between the Absorb bioresorbable vascular scaffold (BVS) and the analogous everolimus-eluting